2659 — Shanghai Bao Pharmaceuticals Co Balance Sheet
0.000.00%
- HK$29.27bn
- HK$28.22bn
- CNY49.16m
Annual balance sheet for Shanghai Bao Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IFRS | IFRS | — |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 322 | 524 | 1,242 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 30.6 | 44 | 0.098 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 366 | 666 | 1,363 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 587 | 678 | 734 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 974 | 1,363 | 2,217 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 147 | 196 | 331 |
| Long Term Debt | |||
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Deferred Income Tax | |||
| Total Other Liabilities | |||
| Total Liabilities | 225 | 367 | 625 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 749 | 996 | 1,592 |
| Total Liabilities & Shareholders' Equity | 974 | 1,363 | 2,217 |
| Total Common Shares Outstanding |